Skip to content

A Prospective Study of Fractional Flow Reserve Assessment of Intermediate Coronary Stenoses in Severe Aortic Stenosis

A Prospective Study of Fractional Flow Reserve Assessment of Intermediate Coronary Stenoses in Severe Aortic Stenosis

Status
Terminated
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03442400
Enrollment
5
Registered
2018-02-22
Start date
2018-02-14
Completion date
2021-08-10
Last updated
2023-01-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Aortic Stenosis, Coronary Artery Stenoses

Keywords

Coronary Artery Stenoses, Aortic Stenosis

Brief summary

Coronary artery blockages can reduce blood flow to the heart muscle. Fractional flow reserve (iFR or FFR) assessment is an invasive tool used to determine how much blood flow is reduced. The investigators will perform iFR/FFR on all intermediate coronary stenoses using standard practice, immediately before (at the time of) transcatheter aortic valve replacement (TAVR) and after successful TAVR. The investigators will compare pre- and post-TAVR iFR/FFR values, and assess short-term outcomes. The investigators hypothesize that iFR/FFR values will be consistently and significantly higher pre-TAVR in comparison with post-TAVR for the same lesions.

Detailed description

The purpose of the study is to determine whether iFR assessment gives a valid assessment of coronary hemodynamics in patients with severe aortic stenosis. Several factors confound the interpretation of fractional flow reserve (FFR) in patients with severe aortic stenosis (AS) and intermediate severity coronary stenoses, and the widely accepted cut-off value of 0.80 may not be applicable to this patient population. Coronary flow reserve is known to be attenuated under conditions of left ventricular hypertrophy and severe AS, with one study showing improvement in coronary flow reserve after aortic valve replacement. Left ventricular hypertrophy produces fixed resistance secondary to external compression of the coronary microcirculation. This potentially results in failure to achieve maximal hyperemia with adenosine and can lead to false negative FFR results. Neurohormonal influences in aortic stenosis can further attenuate vasodilator response and potentially result in false negative FFR values. Both of these conditions result in the potential deferral of lesions which may have been hemodynamically significant in the absence of severe AS. At present, there are no studies which have demonstrated validity of FFR measurement in patients with severe AS. Here, the investigators propose a prospective study of iFR/FFR in patients with AS and indeterminate coronary lesions undergoing TAVR to understand the hemodynamic consequences of AS on iFR/FFR. The investigators hypothesize that iFR/FFR values will be consistently and significantly higher pre-TAVR in comparison with post-TAVR for the same lesions.

Interventions

DEVICEVolcano iFR/FFR Verrata Plus coronary pressure/flow wire

We will measure the degree of flow-limitation of intermediate severity coronary steonses using the iFR/FFR Verrata Plus coronary pressure/flow wire before and after transcatheter aortic valve replacement.

Sponsors

Volcano Corporation
CollaboratorINDUSTRY
The Cleveland Clinic
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
DIAGNOSTIC
Masking
NONE

Intervention model description

A single group of patients with severe aortic stenosis and intermediate coronary stenoses will undergo coronary physiology assessment with iFR/FFR before and after transcatheter aortic valve replacement.

Eligibility

Sex/Gender
ALL
Age
20 Years to 110 Years
Healthy volunteers
No

Inclusion criteria

* All patients who have coronary stenoses between 40-70% severity and who have severe aortic stenosis undergoing TAVR work-up.

Exclusion criteria

* Patients with documented intraprocedural hemodynamic instability, shock, or major adverse event (myocardial infarction, aortic rupture/dissection, stroke, left ventricular perforation, cardiac arrest). * Contraindication to adenosine, presence of cardiogenic shock, presence of acute coronary syndrome.

Design outcomes

Primary

MeasureTime frameDescription
FFR Values Prior to Transcatheter Aortic Valve ReplacementImmediately prior to transcatheter aortic valve replacement, during the index procedureHemodynamic significance of a coronary stenosis by measuring FFR immediately prior to TAVR
FFR Values During the Transcatheter Aortic Valve Replacement (TAVR)Immediately after transcatheter aortic valve replacement, during the index procedureHemodynamic significance of a coronary stenosis by measuring FFR immediately after TAVR

Countries

United States

Participant flow

Participants by arm

ArmCount
FFR/iFR Arm
Volcano iFR/FFR Verrata Plus coronary pressure/flow wire Volcano iFR/FFR Verrata Plus coronary pressure/flow wire: We will measure the degree of flow-limitation of intermediate severity coronary steonses using the iFR/FFR Verrata Plus coronary pressure/flow wire before and after transcatheter aortic valve replacement.
5
Total5

Baseline characteristics

CharacteristicFFR/iFR Arm
Age, Categorical
<=18 years
0 Participants
Age, Categorical
>=65 years
5 Participants
Age, Categorical
Between 18 and 65 years
0 Participants
Diabetes2 Participants
Hyperlipidemia5 Participants
Hypertension5 Participants
Kidney disease0 Participants
Previous MI0 Participants
Previous percutaneous coronary intervention0 Participants
Race (NIH/OMB)
American Indian or Alaska Native
0 Participants
Race (NIH/OMB)
Asian
0 Participants
Race (NIH/OMB)
Black or African American
0 Participants
Race (NIH/OMB)
More than one race
0 Participants
Race (NIH/OMB)
Native Hawaiian or Other Pacific Islander
0 Participants
Race (NIH/OMB)
Unknown or Not Reported
0 Participants
Race (NIH/OMB)
White
5 Participants
Sex: Female, Male
Female
4 Participants
Sex: Female, Male
Male
1 Participants

Adverse events

Event typeEG000
affected / at risk
deaths
Total, all-cause mortality
0 / 5
other
Total, other adverse events
0 / 5
serious
Total, serious adverse events
0 / 5

Outcome results

Primary

FFR Values During the Transcatheter Aortic Valve Replacement (TAVR)

Hemodynamic significance of a coronary stenosis by measuring FFR immediately after TAVR

Time frame: Immediately after transcatheter aortic valve replacement, during the index procedure

Population: 1 patient did not have the FFR value documented

ArmMeasureValue (MEAN)Dispersion
FFR/iFR ArmFFR Values During the Transcatheter Aortic Valve Replacement (TAVR)0.91 ratioStandard Error 0.0335099487715
Primary

FFR Values Prior to Transcatheter Aortic Valve Replacement

Hemodynamic significance of a coronary stenosis by measuring FFR immediately prior to TAVR

Time frame: Immediately prior to transcatheter aortic valve replacement, during the index procedure

Population: 1 patient did not have the FFR value documented

ArmMeasureValue (MEAN)Dispersion
FFR/iFR ArmFFR Values Prior to Transcatheter Aortic Valve Replacement0.86 ratioStandard Error 0.0330088372006

Source: ClinicalTrials.gov · Data processed: Feb 26, 2026